Botanix Pharmaceuticals Limited Total Current Liabilities

Botanix Pharmaceuticals Limited (BOT.AX) currently reports a total current liabilities of $31M as of June 2026. That compares with $25M in the prior-year period — up 24.1% year over year. Use the charts on this page to explore Botanix Pharmaceuticals Limited's total current liabilities history and peer comparisons.

Botanix Pharmaceuticals Limited's total current liabilities increased from $25M to $31M — a 24.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Botanix Pharmaceuticals Limited reported $31M in total current liabilities as of June 2026. That compares with $25M in the prior-year period — up 24.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Botanix Pharmaceuticals Limited, and consider following BOT.AX for alerts when major investors trade the stock.

Botanix Pharmaceuticals Limited is classified in the Healthcare sector. On total current liabilities, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BOT.AX with unrelated industries.